3,511 results found

As previously reported, Health Canada had advised that beginning on October 1, 2018, it would implement certain proposals for its prescription drug product transparency initiatives.

Matt Maurer published his article on the upcoming Senate discussion on the legalization of marijuana and the state of its legalization in Canada.

Litigator Matt Maurer's article "Canadian Senate to Discuss Cannabis Legalization on January 31" was republished by Slaw on January 24, 2017.

Chair of the Cannabis Law Group, Matt Maurer, was quoted in Marijuana.com about whether the Senate could delay Bill C-45, known as the Cannabis Act, from coming into force...

Cannabis grown in unlicensed rooms by cannabis producer CannTrust could meet the legal definition of "illicit cannabis," lawyers say, but an exception in the law means Canadian consumers don't need to worry about possessing that forbidden weed.

Producers and processers in Alberta looking to promote their locally made food products now have help thanks to a new labelling system.

On February 2, the FCA allowed Apotex's appeal of a $61 million award disgorging Apotex's profits for its generic perindopril (COVERSYL).

The provisions relating to confidential third-party rebates will not come into force at the same time as the other provisions.

With the introduction of the new Safe Foods for Canadians Act, more than 50,000 participants in the food sector will come under Federal jurisdiction for the first time.

On October 18, 2014, proposed regulations seeking to amend the Medical Devices Regulations (Regulations) were published in the Canada Gazette.

On June 3, 2020, a proposed class action was commenced against over 50 generic drug manufacturers.

On Feb. 27, 2019 SOL Global Investments Corp. (CSE: SOL) (OTCQB: SOLCF) (Frankfurt: 9SB) announced the closing of its latest investment in European Cannabis Holdings ("ECH").

Agriculture and Agri-Food Canada’s Overview of the Canadian Agriculture and Agri-Food System 2013 describes Canada’s agriculture and agri-food system as a "modern, highly complex, integrated, internationally competitive and growing part of the Canadian economy."

In December 2017, Royal Assent was given to Bill 26: An Act to Control and Regulate Cannabis ("Bill 26").

The FCA affirmed the FC's finding that the ‘191 Patent failed to sufficiently disclose how to synthesize the claimed compound.

In Galderma Canada Inc. v. Canada (Attorney General), 2024 FCA 208, the Federal Court of Appeal (FCA) confirmed that the Patented Medicine Prices Review Board (PMPRB)...

On July 25, 2025, Health Canada released its annual 2024–2025 Statistical Report for the Patented Medicines (Notice of Compliance) Regulations, Data Protection...

We have previously written about the benefits of licensing as a way to get the drug remdesivir quickly deployed during the COVID-19 pandemic.